A detailed history of Fukoku Mutual Life Insurance CO transactions in Moderna, Inc. stock. As of the latest transaction made, Fukoku Mutual Life Insurance CO holds 1,933 shares of MRNA stock, worth $127,094. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,933
Previous 1,933 -0.0%
Holding current value
$127,094
Previous $205,000 11.71%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$85.37 - $115.44 $165,020 - $223,145
1,933 New
1,933 $205,000
Q4 2022

Jan 31, 2023

BUY
$118.38 - $210.04 $19,532 - $34,656
165 Added 9.33%
1,933 $347,000
Q1 2022

May 10, 2022

SELL
$126.46 - $235.05 $202,336 - $376,080
-1,600 Reduced 47.51%
1,768 $305,000
Q4 2021

Jan 25, 2022

BUY
$225.82 - $368.51 $381,184 - $622,044
1,688 Added 100.48%
3,368 $855,000
Q3 2021

Nov 09, 2021

BUY
$221.9 - $484.47 $372,792 - $813,909
1,680 New
1,680 $647,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Fukoku Mutual Life Insurance CO Portfolio

Follow Fukoku Mutual Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fukoku Mutual Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Fukoku Mutual Life Insurance CO with notifications on news.